U.S. Mortgage Finance Stock News

Ocular Therapeutix stock moves Ocular Therapeutix (OCUL) has been drawing attention after a stretch of weak share performance, with the stock down 6.3% on the day and declining over the past week, month, and past 3 months. See our latest analysis for Ocular Therapeutix. That weak one day share price move sits on top of a fading trend, with the 30 day share price return down 14.51%, the year to date share price return down 30.20%, and the 1 year total shareholder return down 8.54%, even though...

RenaissanceRe Holdings (RNR) is back on investor radars after recent share price swings, with the stock up 3.9% over the past day but down over the past month and the past 3 months. See our latest analysis for RenaissanceRe Holdings. Zooming out, RenaissanceRe’s recent 1-day share price gain of 3.87% to $288.48 contrasts with a weaker 30-day share price return of 3.89% and a year-to-date gain of 5.97%. At the same time, the 1-year total shareholder return of 17.59% and 5-year total...

In its recent quarterly report, 1st Source Corp. posted higher profit, raised its dividend, and increased loan loss reserves to address ongoing economic uncertainty and credit risks. An important takeaway is management’s emphasis on safety and soundness, with a proactive reserve build that may reassure investors about risk management discipline. We will now explore how the profit growth and higher dividend shape 1st Source’s broader investment narrative for current and prospective...

Earlier this week, Cardinal Health reported Q3 fiscal 2026 results that exceeded estimates and raised its full-year adjusted EPS and free cash flow guidance, alongside updates on theranostics expansion and a voluntary recall of certain alcohol prep pads. The combination of upgraded outlook and continued investment in its Center for Theranostics Advancement highlighted management’s confidence in Cardinal Health’s higher-value growth initiatives, even as the company managed operational and...

Snap (SNAP) continues to draw attention after recent trading left the stock at US$5.76, with mixed short term returns and an ongoing loss position shaping how investors assess its risk and potential reward. See our latest analysis for Snap. Recent trading has been choppy, with the 1 day share price return down 5.11% and the 30 day share price return down 5.26%. A 90 day share price return of 12.28% suggests that momentum has cooled after a stronger spring, set against a 1 year total...

In May 2026, PROCEPT BioRobotics reported two milestones in its WATER IV prostate cancer program: full enrollment of the 280‑patient randomized trial comparing Aquablation therapy with radical prostatectomy, and FDA IDE approval for a second global randomized study comparing Aquablation with active surveillance. By positioning Aquablation against both the surgical standard of care and active surveillance, PROCEPT is testing whether its robotic waterjet approach can expand treatment options...

China Yuchai International (CYD) has drawn fresh investor attention after its recent share performance, with the stock up about 23% over the past month and roughly 37% in the past 3 months. See our latest analysis for China Yuchai International. Zooming out, the 22.75% 1 month share price return and 53.32% year to date share price return sit alongside a very large 1 year total shareholder return. Momentum remains positive despite a small 1 day pullback of 2.41%. If this move has you thinking...

In late May 2026, Silicon Motion Technology Corporation announced the SM2524XT, a PCIe Gen5 DRAMless SSD controller built on TSMC’s 6nm process, delivering up to 14 GB/s sequential reads, up to 2.5 million IOPS random performance, and up to 25% higher performance per watt versus its previous generation. By directly targeting KV Cache and AI inference workloads with features such as Separated Command Address technology and advanced FTL scheduling, the SM2524XT positions Silicon Motion to...

O'Reilly Automotive (ORLY) expanded its share repurchase authorization by an additional US$2.0b to a total of US$31.75b and extended the program by three years, bringing capital returns back into focus for investors. See our latest analysis for O'Reilly Automotive. The buyback update comes as the stock trades at US$90.33, with a 1-day share price return of 2.18% and a 7-day share price return of 3.97%. The 1-year total shareholder return is slightly down 1.65%, while the 5-year total...

Federal National Mortgage Association (FNMA) has introduced a new Fannie Mae backed mortgage product that accepts Bitcoin as collateral for down payments, through a partnership with Coinbase and Better Mortgage. See our latest analysis for Federal National Mortgage Association. The Bitcoin backed mortgage launch comes after a period of pressure on the stock, with the share price down 14.8% over 30 days and 39.1% year to date, while the 3 year total shareholder return remains very large...

PureCycle Technologies (PCT) is back in focus after its Thailand subsidiary was admitted to the Thailand FastPass Investment Acceleration Program, tying the stock story more closely to its planned Rayong polypropylene recycling facility. See our latest analysis for PureCycle Technologies. The Thailand FastPass news lands after a sharp 112.84% 90 day share price return and a 31.32% 30 day share price return, even though the stock fell 10.29% on the day. A 26.67% 1 year total shareholder return...

NPK International (NPKI), a US based temporary worksite access solutions company, recently completed its rebrand from Newpark Resources, bringing fresh attention to a stock with mixed short term and longer term return profiles. See our latest analysis for NPK International. At a share price of US$14.28, NPK International has cooled in the very short term, with the share price down 2.33% over 1 day and 4.48% over 30 days. However, the year to date share price return of 18.02% and 1 year total...

CBL & Associates Properties (CBL) is back in focus after selling a 10.47 acre parcel near Harford Mall and lining up new retailers and restaurants at West County Center, including The Cheesecake Factory and POP MART. See our latest analysis for CBL & Associates Properties. These tenant additions and land sales sit against a solid run in the stock, with a 90-day share price return of 26.75% and a 1-year total shareholder return of 100.90%. This points to momentum that investors are watching...

Public Service Enterprise Group has recently completed a US$499.31 million fixed-income offering of 4.800% senior unsecured notes due June 15, 2031, priced at 99.861% of the US$500 million principal, and filed to cut New Jersey residential gas heating bills by 5% from October 1, 2026. Together, the bond issuance and planned bill reduction highlight how PSE&G is funding its capital needs while emphasizing affordability for its 1.9 million gas customers. With this planned 5% cut to residential...

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...

Kodiak Sciences recently reported that its Phase III GLOW2 trial of Zenkuda for diabetic retinopathy met primary and key secondary endpoints with strong efficacy, and the company is also advancing multiple late-stage ophthalmology programs while maintaining a solid, debt-free balance sheet. This combination of positive late-stage data and an accelerated regulatory submission plan highlights how central Zenkuda has become to Kodiak’s overall pipeline story. Next, we’ll examine how Zenkuda’s...

IDEAYA Biosciences (IDYA) has moved into focus after two clinical updates, a new collaboration with Roche on IDE892 plus RG6505 in MTAP deleted pancreatic cancer, and Phase 2/3 darovasertib data in metastatic uveal melanoma. See our latest analysis for IDEAYA Biosciences. Despite the recent collaboration with Roche and positive darovasertib data at ASCO, IDEAYA Biosciences’ share price has come under pressure in recent months, with a 90 day share price return down 19.4%, although the 1 year...

In the first quarter of 2026, Melco Resorts & Entertainment’s Macau properties generated 87% of group gross gaming revenue and 75% of EBITDA, with both metrics expanding year-on-year and quarter-on-quarter alongside a 1.3 percentage point gain in Macau gross gaming revenue market share. This outperformance in Macau, coupled with Melco’s ongoing support for inclusion-focused events such as the 2026 Inclusion Conference & Festival and the Macau Golf Masters, highlights how operational strength...

In late April 2026, Weyerhaeuser reported Q1 results that topped expectations, with US$1.73 billion in net sales, US$77 million in adjusted net earnings, and completion of a US$192 million divestiture of 108,000 acres of non-core Virginia timberlands. Beyond the quarterly beat, the sale of lower-priority timberlands and progress in higher-margin Wood Products and Strategic Land Solutions highlight how Weyerhaeuser is reshaping its portfolio toward higher-return uses of its asset base. Next,...

Pilgrim's Pride (PPC) is back in focus after recent analyst commentary highlighted expectations for lower earnings this quarter and for the fiscal year, alongside a Zacks Rank #5 (Strong Sell) rating. See our latest analysis for Pilgrim's Pride. At a share price of US$29.88, Pilgrim's Pride has seen short term strength with a 1 day share price return of 3.14% and a 7 day gain of 5.55%. However, momentum has faded over the past quarter, with the 90 day share price return down 24.79% and the 1...

In recent developments, Energy Vault Holdings reported very large year-over-year revenue growth for fiscal 2025, driven by project execution in Australia and the U.S., the ramp-up of its Asset Vault portfolio, and US$450 million of new strategic financing, while shareholders reelected three Class II directors and ratified BDO USA, P.C. as auditor for the fiscal year ending December 31, 2026. Together, the rapid expansion of contracted capacity to 540 megawatts and the move into AI-focused...

C.H. Robinson Worldwide recently launched its Lean AI Engineer, an AI system that can assess and optimize a shipper’s global supply chain in under 30 minutes, working alongside the existing Lean AI Planner to autonomously manage the vast majority of 4PL shipments across trucking, ocean, air, and rail. Early customer results highlight how this AI platform can uncover hidden efficiencies and cost savings, such as materially reducing shipment frequency and load counts by reconfiguring schedules...

Qorvo (QRVO) is back in focus after its latest quarterly report delivered revenue and adjusted earnings above analyst estimates. The results were helped by tighter cost control and a product mix that is less exposed to soft smartphone demand. See our latest analysis for Qorvo. Despite a 1-day share price decline of 5.47% to US$98.28 after the report, Qorvo still shows a 30 day share price return of 8.56% and a 1 year total shareholder return of 25.07%. However, 5 year total shareholder...

In the past quarter, Cullen/Frost Bankers reported year-on-year revenue growth but missed analysts’ expectations, particularly on net interest income and overall revenues. This mixed outcome highlights the tension between Frost’s expanding Texas franchise and near-term pressure on its core banking income streams. Next, we’ll examine how the net interest income shortfall interacts with Frost’s Texas-focused growth narrative and long-term profitability assumptions. We've uncovered the 9...